Johnson & Johnson (JNJ)
222.37
-2.25
(-1.00%)
USD |
NYSE |
May 07, 16:00
222.01
-0.36
(-0.16%)
After-Hours: 17:24
Johnson & Johnson Cash from Investing (Quarterly) : -1.04B for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Biogen, Inc. | -209.50M |
| Gilead Sciences, Inc. | -1.835B |
| Protagonist Therapeutics, Inc. | 90.89M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.514B |
| Cash from Financing (Quarterly) | 530.00M |
| Free Cash Flow | 17.80B |
| Free Cash Flow Per Share (Quarterly) | 0.5991 |
| Free Cash Flow to Equity (Quarterly) | -4.189B |
| Free Cash Flow to Firm (Quarterly) | 1.830B |
| Free Cash Flow Yield | 3.29% |